23andMe has bought the rights to develop a drug primarily based on its customers’ DNA

Shopper genomics agency 23andMe has signed its first deal to promote the rights to develop a brand new drug for inflammatory ailments to a pharmaceutical firm

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker